Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
ONCY
Primary Symbol:
T.ONC
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 05, 2024 6:00pm
RE:RE:RE:RE:RE:CAR-T update
November 05, 2024 - Arcellx: its BCMA-targeting Car-T contender anitocabtagene autoleucel, 3 deaths among 58 patients in its Phase 2 Immagine-1 trial and a market cap of US$4.6 Billion
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 05, 2024 5:21pm
RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
The IRA marks a significant milestone in the ongoing debate over prescription drug pricing in the United States. While there are valid concerns about its impact on the pharmaceutical industry's
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(95)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Nov 05, 2024 3:41pm
RE:Though forward …??
I think you mean "fund" the mBC product trial... and just to be clear accelerated approval is a MINIMUM of 2 years away... It may be accelerated approval by definition, but by the time it
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 05, 2024 12:35pm
RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China
What Might Future Commercial Models Look Like? The IRA may compel pharmaceutical companies to rethink their commercial models and review their portfolios, prioritizing therapeutic areas where unmet
...more
(78)
•••
venture009
X
View Profile
View Bullboard History
Comment by
venture009
on Nov 04, 2024 6:14pm
RE:RE:Another Fine Start To The Week
Allowing cash to drop below 12 months operating I believe is a first. Let's hope this suggests something of significance is abot to happen. However, you have to wonder how seriously BP will
...more
(206)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 04, 2024 3:43pm
RE:RE:Another Fine Start To The Week
What we need is a fireside chat !!!! The will get the stock to moving.... down.
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 04, 2024 1:11pm
RE:RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
In a break from the pattern of global deal volumes, average deal premiums indicate that there’s overall more interest in pharma deal activity than 10 years ago. These premiums reflect the average
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 04, 2024 12:19pm
RE:RE:SITC 2024 - Nov.06 - Nov.10 - Houston TX.
Wednesday, Nov. 6, 2024 - Tumor Infiltrating Lymphocytes (TIL) Symposium Wednesday, Nov. 6, 2024 - Beyond Checkpoint Inhibitors: New Immuno-oncology Modalities and Approaches
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 04, 2024 12:01pm
RE:SITC 2024 - Nov.06 - Nov.10 - Houston TX.
Session 107c: Timing and Combination of Systemic Therapies in Solid Cancers Framework for Novel Combination Immunotherapy Development Informed by the TME - Jason Luke, MD, FACP - UPMC
...more
(206)
•••
Buckhenry
X
View Profile
View Bullboard History
Comment by
Buckhenry
on Nov 04, 2024 11:52am
RE:Another Fine Start To The Week
The only thing we know for sure is they are running low on funds and will have to cut some kinda of deal in the near future... good or bad. But please continue to be patient...
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Post by
Noteable
on Nov 04, 2024 11:52am
SITC 2024 - Nov.06 - Nov.10 - Houston TX.
Keynote Address: " What is T Cell Exhaustion?" https://www.sitcancer.org/2024/schedule/sitc24-annualmeeting
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 04, 2024 11:14am
RE:RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
M&A activity is expected to pick up in 2025: The value of M&A deals in life sciences reached US$163bn in 2023 (deals announced up to the end of October), surpassing the US$135bn
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 04, 2024 10:53am
RE:RE:RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A Deals
All that's necessary is nine zeros
(0)
•••
Ghosttwo
X
View Profile
View Bullboard History
Comment by
Ghosttwo
on Nov 04, 2024 10:42am
RE:Another Fine Start To The Week
How many zeros are in a gazillion?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden